close

Enter

Log in using OpenID

Contrast Media Contrast Agent Market

embed
Contrast media or contrast agent is used in medical imaging to enhance the image of body parts generated through X-rays, magnetic resonance imaging (MRI), computed tomography (CT), and ultrasound.
Contrast Media/Contrast Agent Market Trends,
Outlook, and Opportunity Analysis, 2018 2026, GE Healthcare
Contrast media or contrast agent is used in medical imaging to enhance the image of body
parts generated through X-rays, magnetic resonance imaging (MRI), computed tomography (CT),
and ultrasound. These substances are momentarily used to change the way imaging tools or xrays interact with the body. Contrast media or contrast agent help the physicians to diagnose
the medical conditions by improving the visibility of blood vessels or tissues and specific
organs. These substances are added into the body prior to an imaging scan to help distinguish
certain structures or tissues of interest from the surrounding tissue. Contrast media or contrast
agent can be administered into the body in one of the four ways which include by enema
(given rectally), orally, urethral, and by injecting into a blood vessel.
Request Sample Copy of Research Report @
https://www.coherentmarketinsights.com/insight/request-sample/1210
Rise in the gas micro bubble technology in MRI imaging is expected to boost the growth of
contrast media/contrast agent market:
The major factors driving the growth of contrast Media/contrast agent are the use of advanced
technology such as gas micro bubble technology in MRI imaging, rising incidence of chronic
diseases such as cardiac diseases, gastrointestinal disorders, and cancer. Advancements in
medical imaging technology and increasing demand for image guided procedures and diagnostics
is fueling the growth of the market. According to the International Agency for Research on
Cancer (IARC), in 2012, an estimated 14.1 million new cancer cases and 8.2 million cancer
deaths were recorded worldwide and by 2030 the number is expected to escalate to 21.7
million for new cancer cases and 13 million cancer deaths. However, side effects of contrast
agents such as kidney diseases and high cost associated with the contrast media injectors are
some of the factors that are hindering the growth of contrast media/ contrast agent market.
Increasing incidence of cancer and cardiac disorders is expected to dominate North America
region in contrast media/contrast agent market:
On the basis of region, the global contrast media/contrast agent market is segmented into North
America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America
dominates the contrast media/ contrast agent in the global market, followed by Europe.
Improved MRI techniques in cardiovascular diseases, rise in the number of cancer and cardiac
disorders, advancements in diagnostic technology, image guided surgical procedures are the
factors that has propelled the growth of contrast media/contrast agent market in the North
America region. According to the National Cancer Institute, in 2016, an estimated 1,685,210
new cases of cancer were diagnosed in the U.S. Also, according to the Centers for Disease
Control and Prevention (CDC), 2017, an estimated 28.4 million heart cases were diagnosed in
the U.S.
Report includes chapters which deeply display the following deliverable about industry :
• Contrast Media/Contrast Agent Market Research Objective and Assumption
• Contrast Media/Contrast Agent Market Purview - Report Description, Executive Summary, and
Coherent Opportunity Map (COM)
• Contrast Media/Contrast Agent Market Dynamics, Regulations, and Trends Analysis - Market
Dynamics, Regulatory Scenario, Industry Trend, Merger and Acquisitions, New system
Launch/Approvals, Value Chain Analysis, Porter’s Analysis, and PEST Analysis
• Global Contrast Media/Contrast Agent Market , By Regions
• Contrast Media/Contrast Agent Market Competition by Manufacturers including Production,
Share, Revenue, Average Price, Manufacturing Base Distribution, Sales Area and Product Type.
• Contrast Media/Contrast Agent Market Manufacturers Profiles/Analysis including Company
Basic Information, Manufacturing Base and Its Competitors.
• Contrast Media/Contrast Agent Market Manufacturing Cost Analysis including Key Raw
Materials and Key Suppliers of Raw Materials.
• Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials
Sourcing and Downstream Buyers
• Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market
Positioning and Distributors/Traders List.
• Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer
Preference Change and Economic/Political Environmental Change.
• Contrast Media/Contrast Agent Market Forecast including Production, Consumption, Import
and Export Forecast by Type, Applications and Region.
• Research Findings and Conclusion
Key players operating in the market:
In March, 2017, GE Healthcare has launched Clariscan, a gadolinium based contrast agent
designed to support effective visualization of abnormalities in the spine, brain and associated
tissues. Clariscan, also known to be a gold standard detection tool in MR imaging, allows
prompt detection of abnormalities by helping in improving contrast between pathological and
normal tissue.
The key players operating in the contrast media/contrast agent market include Lantheus Medical
Imaging, GE Healthcare, Bayer HealthCare, Bracco Imaging S.p.A, NanoPET Pharma GmbH,
Guerbet Group, CMC Contrast AB, Daiichi Sankyo, and Subhra Pharma Private Limited.
Inquire Here Before Purchase of Research Report @
https://www.coherentmarketinsights.com/insight/talk-to-analyst/1210
Contrast Media/ Contrast Agent Market Taxonomy:
Contrast Media/ Contrast Agent Market is segmented on the basis of media type, route of
administration, indication, end user and geography.
On the basis of media type, contrast media/contrast agent market is segmented into:
• Microbubble Contrast Media
• Iodinated Contrast Media
• Barium-Based Contrast Media
• Gadolinium-Based Contrast Media
On the basis of route of administration, contrast media/contrast agent market is segmented into:
• Oral
• Rectal
• Intravenous
• Urethral
On the basis of indication, contrast media/contrast agent market is segmented into:
• Neurological Disorders
• Nephrological Disorders
• Cardiovascular Disorders
• Gastrointestinal Disorders
• Oncology
• Musculoskeletal Disorders
On the basis of end user, contrast media/contrast agent market is segmented into:
• Hospitals
• Ambulatory Surgical Centers
• Diagnostic Clinics
For More Information Visit Here @
https://www.coherentmarketinsights.com/ongoing-insight/contrast-media-contrast-agent-market1210
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering actionready syndicated research reports, custom market analysis, consulting services, and competitive
analysis through various recommendations related to emerging market trends, technologies, and
potential absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: [email protected]
Author
Alex Huge
Alex Huge339   documents Email
Document
Category
Health and Medicine
Views
13
File Size
125 KB
Tags
media, Contrast Media/Contrast Agent Market
1/--pages
Report inappropriate content